Pfizer Inc.

PFENYSE

$30.28

Last price · USD

Market cap: $172.2B
P/E: 22.3x
EV / EBITDA: 14.2x
P/S: 2.8x
FCF yield: 5.3%
Div. yield: 5.68%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

Pfizer Inc. balance sheet

Annual · USD millions except per-share data · 48 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Current assets
Cash & cash equivalents	1,142	1,043	2,853	416	1,944	-12.5%
Short-term investments	12,454	19,434	9,837	22,316	29,125	-19.1%
Cash & short-term investments	13,596	20,477	12,690	22,732	31,069	-18.7%
Net receivables	15,841	14,777	15,544	14,529	15,745	+0.2%
Accounts receivable	11,874	11,463	11,566	10,952	11,479	+0.8%
Other receivables	3,967	3,314	3,978	3,577	4,266	-1.8%
Inventory	10,654	10,851	10,189	8,981	9,059	+4.1%
Other current assets	2,807	4,253	4,910	5,017	3,820	-7.4%
Total current assets	42,898	50,358	43,333	51,259	59,693	-7.9%
Non-current assets
Property, plant & equipment (net)	21,530	18,393	18,940	16,274	14,882	+9.7%
Goodwill	71,264	68,527	67,783	51,375	49,208	+9.7%
Intangible assets	53,731	55,412	64,900	43,370	25,146	+20.9%
Goodwill & intangible assets	124,995	123,939	132,683	94,745	74,354	+13.9%
Long-term investments	1,737	2,227	15,368	15,069	21,526	-46.7%
Tax assets	9,699	8,662	3,706	6,693	3,341	+30.5%
Other non-current assets	7,301	9,817	12,471	13,163	7,679	-1.3%
Total non-current assets	165,262	163,038	183,168	145,944	121,782	+7.9%
Other assets	0	0	0	3	2	—
Total assets	208,160	213,396	226,501	197,206	181,477	+3.5%
Current liabilities
Accounts payable	5,240	5,633	6,710	6,809	5,578	-1.6%
Other payables	5,548	5,347	4,721	3,890	3,515	+12.1%
Total payables	10,788	10,980	11,431	10,699	9,093	+4.4%
Short-term debt	3,484	6,946	10,346	2,934	2,241	+11.7%
Capital lease obligations (current)	0	356	0	0	0	—
Tax payables	0	0	2,349	1,587	1,266	—
Deferred revenue	784	1,511	2,700	2,520	3,067	-28.9%
Other current liabilities	18,318	23,202	23,317	25,985	28,270	-10.3%
Total current liabilities	36,984	42,995	47,794	42,138	42,671	-3.5%
Non-current liabilities
Long-term debt	61,641	57,405	60,499	31,925	34,757	+15.4%
Capital lease obligations (non-current)	2,291	2,286	0	0	0	—
Deferred tax liabilities (non-current)	2,401	2,122	640	1,023	349	+62.0%
Other non-current liabilities	18,068	20,091	28,280	26,203	26,237	-8.9%
Total non-current liabilities	84,401	81,904	89,419	59,151	61,343	+8.3%
Capital lease obligations	2,291	2,642	0	0	0	—
Total debt	67,416	66,993	70,845	34,859	36,998	+16.2%
Total liabilities	121,385	124,899	137,213	101,289	104,014	+3.9%
Stockholders' equity
Common stock	481	480	478	476	473	+0.4%
Retained earnings	114,610	116,725	118,353	125,656	103,394	+2.6%
Additional paid-in capital	94,469	93,603	92,631	91,802	90,591	+1.1%
Treasury stock	(115,015)	(114,763)	(114,487)	(113,969)	(111,361)	—
Accumulated other comprehensive income (loss)	(8,069)	(7,842)	(7,961)	(8,304)	(5,897)	—
Total stockholders' equity	86,476	88,203	89,014	95,661	77,201	+2.9%
Total equity	86,775	88,497	89,288	95,917	77,463	+2.9%
Minority interest	299	294	274	256	262	+3.4%
Total liabilities & equity	208,160	213,396	226,501	197,206	181,477	+3.5%
Additional fields
Accrued Expenses	3,610	0	0	0	0	—
Net Debt	66,274	65,950	67,992	34,443	35,054	+17.3%
Total Investments	14,191	21,661	25,205	37,385	50,651	-27.2%

Pfizer Inc.

PFENYSE

$30.28

Last price · USD

Market cap: $172.2B
P/E: 22.3x
EV / EBITDA: 14.2x
P/S: 2.8x
FCF yield: 5.3%
Div. yield: 5.68%

Multiples use last price and FY2025 annual figures. Market cap estimated from diluted shares.

Pfizer Inc. balance sheet

Annual · USD millions except per-share data · 48 lines

Fiscal year	2025latest	2024	2023	2022	2021	CAGR
Current assets
Cash & cash equivalents	1,142	1,043	2,853	416	1,944	-12.5%
Short-term investments	12,454	19,434	9,837	22,316	29,125	-19.1%
Cash & short-term investments	13,596	20,477	12,690	22,732	31,069	-18.7%
Net receivables	15,841	14,777	15,544	14,529	15,745	+0.2%
Accounts receivable	11,874	11,463	11,566	10,952	11,479	+0.8%
Other receivables	3,967	3,314	3,978	3,577	4,266	-1.8%
Inventory	10,654	10,851	10,189	8,981	9,059	+4.1%
Other current assets	2,807	4,253	4,910	5,017	3,820	-7.4%
Total current assets	42,898	50,358	43,333	51,259	59,693	-7.9%
Non-current assets
Property, plant & equipment (net)	21,530	18,393	18,940	16,274	14,882	+9.7%
Goodwill	71,264	68,527	67,783	51,375	49,208	+9.7%
Intangible assets	53,731	55,412	64,900	43,370	25,146	+20.9%
Goodwill & intangible assets	124,995	123,939	132,683	94,745	74,354	+13.9%
Long-term investments	1,737	2,227	15,368	15,069	21,526	-46.7%
Tax assets	9,699	8,662	3,706	6,693	3,341	+30.5%
Other non-current assets	7,301	9,817	12,471	13,163	7,679	-1.3%
Total non-current assets	165,262	163,038	183,168	145,944	121,782	+7.9%
Other assets	0	0	0	3	2	—
Total assets	208,160	213,396	226,501	197,206	181,477	+3.5%
Current liabilities
Accounts payable	5,240	5,633	6,710	6,809	5,578	-1.6%
Other payables	5,548	5,347	4,721	3,890	3,515	+12.1%
Total payables	10,788	10,980	11,431	10,699	9,093	+4.4%
Short-term debt	3,484	6,946	10,346	2,934	2,241	+11.7%
Capital lease obligations (current)	0	356	0	0	0	—
Tax payables	0	0	2,349	1,587	1,266	—
Deferred revenue	784	1,511	2,700	2,520	3,067	-28.9%
Other current liabilities	18,318	23,202	23,317	25,985	28,270	-10.3%
Total current liabilities	36,984	42,995	47,794	42,138	42,671	-3.5%
Non-current liabilities
Long-term debt	61,641	57,405	60,499	31,925	34,757	+15.4%
Capital lease obligations (non-current)	2,291	2,286	0	0	0	—
Deferred tax liabilities (non-current)	2,401	2,122	640	1,023	349	+62.0%
Other non-current liabilities	18,068	20,091	28,280	26,203	26,237	-8.9%
Total non-current liabilities	84,401	81,904	89,419	59,151	61,343	+8.3%
Capital lease obligations	2,291	2,642	0	0	0	—
Total debt	67,416	66,993	70,845	34,859	36,998	+16.2%
Total liabilities	121,385	124,899	137,213	101,289	104,014	+3.9%
Stockholders' equity
Common stock	481	480	478	476	473	+0.4%
Retained earnings	114,610	116,725	118,353	125,656	103,394	+2.6%
Additional paid-in capital	94,469	93,603	92,631	91,802	90,591	+1.1%
Treasury stock	(115,015)	(114,763)	(114,487)	(113,969)	(111,361)	—
Accumulated other comprehensive income (loss)	(8,069)	(7,842)	(7,961)	(8,304)	(5,897)	—
Total stockholders' equity	86,476	88,203	89,014	95,661	77,201	+2.9%
Total equity	86,775	88,497	89,288	95,917	77,463	+2.9%
Minority interest	299	294	274	256	262	+3.4%
Total liabilities & equity	208,160	213,396	226,501	197,206	181,477	+3.5%
Additional fields
Accrued Expenses	3,610	0	0	0	0	—
Net Debt	66,274	65,950	67,992	34,443	35,054	+17.3%
Total Investments	14,191	21,661	25,205	37,385	50,651	-27.2%